Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.44 Down 0.10(3.75%) 4:00PM EDT
Prev Close:2.53
Open:2.52
Bid:2.37 x 100
Ask:2.59 x 10000
1y Target Est:7.00
Beta:3.32
Earnings Date:Aug 11 - Aug 18 (Est.)
Day's Range:2.38 - 2.57
52wk Range:1.25 - 6.87
Volume:2,206,302
Avg Vol (3m):1,716,100
Market Cap:200.75M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRADown 3.75%200.75M
DVAXDown 3.38%375.88M
PFEUp 0.56%184.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,850.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback